positive phase II results; phase III to begin 2H2010
Brand N/A Generic fostamatinib disodium (R788)
Company name Rigel, AstraZeneca Product type Speciality
Therapeutic category Immunologic agents Key uses rheumatoid arthritis
Other Uses Immune Thrombocytopenic Purpura (ITP) Drug Class syk kinase inhibitor
Dosage From oral Expected Approval 2012+
FDA Filing N/A Last Update date March 02,2010
Link to pipeline report
Link to news article
Link to clinicaltrials.gov